Co-Authors
This is a "connection" page, showing publications co-authored by Bruno Lina and Manuel Rosa-Calatrava.
Connection Strength
0.516
-
Characterization and Treatment of SARS-CoV-2 in Nasal and Bronchial Human Airway Epithelia. Cell Rep Med. 2020 07 21; 1(4):100059.
Score: 0.223
-
Correction: Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs. J Exp Med. 2021 Oct 04; 218(10).
Score: 0.060
-
Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs. J Exp Med. 2021 10 04; 218(10).
Score: 0.060
-
Antiviral Properties of the NSAID Drug Naproxen Targeting the Nucleoprotein of SARS-CoV-2 Coronavirus. Molecules. 2021 Apr 29; 26(9).
Score: 0.059
-
Transcriptional Profiling of Immune and Inflammatory Responses in the Context of SARS-CoV-2 Fungal Superinfection in a Human Airway Epithelial Model. Microorganisms. 2020 Dec 11; 8(12).
Score: 0.057
-
In vitro evaluation of antiviral activity of single and combined repurposable drugs against SARS-CoV-2. Antiviral Res. 2020 09; 181:104878.
Score: 0.056